Pausing Enhanced Pandemic Pathogen Research Act of 2023

Bill: 118-hr-1827
Sponsor: full_name: Rep. Carter, Earl L. "Buddy" [R-GA-1]
Introduced: 2023-03-28
Policy area: Health
Subjects: Infectious and parasitic diseases

Medical research

National Institutes of Health (NIH)

Research administration and funding
Latest action: action_date: 2023-04-07
text: Referred to the Subcommittee on Health.

Summaries:
action_date: 2023-03-28
action_desc: Introduced in House
text: <p><b>Pausing Enhanced Pandemic Pathogen Research Act of 2023</b></p> <p>This bill generally prohibits the National Institutes of Health from conducting or supporting gain-of-function research through March 30, 2028. The bill defines <i>gain-of-function research </i>as any research that could enhance the transmissibility, virulence, or pathogenicity of any pathogen or non-pathogen agent in a way that could lead to (1) moderate or high transmissibility, virulence, or pathogenicity in human populations; (2) significant morbidity or mortality in humans; or (3) severe threats to public health or U.S. national security.</p> <p>The prohibition does not apply to the characterization or testing of naturally occurring influenza virus or coronavirus unless the characterization or testing could increase viral pathogenicity or transmissibility.</p>

tv_txt: I 118th CONGRESS 1st Session H. R. 1827 IN THE HOUSE OF REPRESENTATIVES March 28, 2023 Mr. Carter of Georgia (for himself, Mr. Cuellar , and Mr. Gallagher ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To prohibit the National Institutes of Health from conducting or supporting certain gain-of-function research, and for other purposes.

1. Short title This Act may be cited as the Pausing Enhanced Pandemic Pathogen Research Act of 2023 . 2. No conduct or support by NIH of gain-of-function research Part A of title IV of the Public Health Service Act ( 42 U.S.C. 281 et seq. ) is amended by adding at the end the following: 404P. Gain-of-function research (a) Prohibition During the period ending on March 30, 2028, the National Institutes of Health shall not conduct or support, directly or indirectly, including through subgrants, any gain-of-function research. (b) Limitation This section does not apply to characterization or testing of any naturally occurring influenza virus or coronavirus, unless the characterization or testing could increase pathogenicity or transmissibility. (c) Gain-of-Function research defined In this section, the term gain-of-function research means any research that could enhance the transmissibility, virulence, or pathogenicity of any pathogen (whether or not classified as a pathogen of pandemic potential) or non-pathogen agent in a way that could result in one or more of the following: (1) The pathogen or agent becoming moderately or highly transmissible, virulent, or pathogenic in human populations. (2) The pathogen or agent causing significant morbidity or mortality in humans. (3) The pathogen or agent posing a severe threat to public health, the capacity of public health systems, or the national security of the United States. .